SARS-CoV-2 disguises its own genetic material to facilitate infection The SARS-CoV-2 virus is able to camouflage itself to promote viral replication, as revealed by structural details of proteins on the surface of the virus. Researchers discovered an enzyme that they believe could be an important target for antiviral drug development, according to a July 14 Nature Communications report.Read More
Life science instrumentation market adapts to COVID-19 To reflect the new realities of the analytical instrumentation market during the COVID-19 pandemic and in the subsequent pandemic-driven recession, Strategic Directions International, a sister company of ScienceBoard.net, has released its revised edition of the Global Assessment Report.Read More
Pall debuts solution for biotech research Pall, one of the largest suppliers of laboratory filtration and clarification products, recently launched two new filtration and clarification plates designed to improve cell and protein purification.Read More
Unveiling bat secrets of immunity could offer clues to treating COVID-19 Bats' longevity and capacity to tolerate viruses may stem from their ability to control inflammation, according to a review article published in Cell Metabolism on July 7. The unique mechanisms that bats employ to achieve this may hold clues to developing new treatments for human diseases.Read More
How has SARS-CoV-2 evolved from bat coronavirus? Structural comparison between a bat coronavirus and SARS-CoV-2 reveals specific characteristics that make the new virus more pathogenic, according to a new article published in Nature Structural and Molecular Biology on July 9.Read More